SEC Form 4 · accession 0001009448-17-000036
NEUROONE MEDICAL TECHNOLOGIES Corp · NMTC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Amer Samad
Director
Period of report
Jul 20, 2017
Accepted (ET)
Aug 7, 2017 · 2:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001500198
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 20, 2017 | J | 3,500,000 | $0.00 | D | 15,728 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
1. The reporting person tendered 3,500,000 shares of common stock of NeuroOne Medical Technologies Corporation("NMTC") for cancellation on July 20, 2017, pursuant to the Agreement and Plan of Merger and Reorganization, dated as of July 20, 2017, betwee NMTC, OSOK Acquisition Company and NeuroOne, Inc. ("NeuroOne"), pursuant to which NeuroOne became a wholly-owned subsidiary of NMTC.